A method and composition for reducing or alleviating inflammation in a subject is provided, including administering to the subject a therapeutically effective amount； of one or more isolated proteins respectively comprising an amino acid sequence set forth in SEQ ID NOS:l-31, or a biologically active fragment or variant thereof or combinations of these to thereby reduce or alleviate inflammation. Inflammation may be associated with a disease is a disease of the digestive tract such as chronic gastritis or an inflammatory bowel disease such as Crohn's disease or ulcerative colitis, or a disease of the respiratory system, such as asthma, emphysema, chronic bronchitis, and chronic obstructive pulmonary disease.
